New Orleans

CYTODYN 24 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against CytoDyn, Inc. - CYDY

Monday, May 17, 2021 - 5:16am

On this news, shares of CytoDyn plummeted.\nThe first-filed case is Lewis v. CytoDyn, Inc., No.

Key Points: 
  • On this news, shares of CytoDyn plummeted.\nThe first-filed case is Lewis v. CytoDyn, Inc., No.
  • 3:21-cv-05190\nAbout Kahn Swick & Foti, LLC\nKSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation\'s premier boutique securities litigation law firms.
  • KSF serves a variety of clients including public institutional investors, hedge funds, money managers and retail investors in seeking to recover investment losses due to corporate fraud and malfeasance by publicly traded companies.
  • KSF has offices in New York, California and Louisiana.\nTo learn more about KSF, you may visit www.ksfcounsel.com .\n'

SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS DOX, FGEN, GOEV, VRM INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

Saturday, May 15, 2021 - 3:50am

b'NEW ORLEANS, May 14, 2021 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (\xe2\x80\x9cKSF\xe2\x80\x9d) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits:\nIf you purchased shares of the above companies and would like to discuss your legal rights and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner, Lewis Kahn, toll-free at 1-877-515-1850, via email (Lewis.Kahn@KSFcounsel.com), or via the case links above.\nIf you wish to serve as a Lead Plaintiff in the class action, you must petition the Court on or before the Lead Plaintiff Motion deadline.\nKSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation\xe2\x80\x99s premier boutique securities litigation law firms.

Key Points: 
  • b'NEW ORLEANS, May 14, 2021 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (\xe2\x80\x9cKSF\xe2\x80\x9d) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits:\nIf you purchased shares of the above companies and would like to discuss your legal rights and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner, Lewis Kahn, toll-free at 1-877-515-1850, via email (Lewis.Kahn@KSFcounsel.com), or via the case links above.\nIf you wish to serve as a Lead Plaintiff in the class action, you must petition the Court on or before the Lead Plaintiff Motion deadline.\nKSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation\xe2\x80\x99s premier boutique securities litigation law firms.
  • KSF serves a variety of clients \xe2\x80\x93 including public institutional investors, hedge funds, money managers and retail investors \xe2\x80\x93 in seeking to recover investment losses due to corporate fraud and malfeasance by publicly traded companies.
  • KSF has offices in New York, California and Louisiana.\nTo learn more about KSF, you may visit www.ksfcounsel.com .\n'

SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS CAN, CS, EBS, RMO INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

Saturday, May 15, 2021 - 3:50am

b'NEW ORLEANS, May 14, 2021 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (\xe2\x80\x9cKSF\xe2\x80\x9d) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits:\nRomeo Power, Inc. (RMO) f/k/a RMG Acquisition Corp. (RMG)\nIf you purchased shares of the above companies and would like to discuss your legal rights and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner, Lewis Kahn, toll-free at 1-877-515-1850, via email (Lewis.Kahn@KSFcounsel.com), or via the case links above.\nIf you wish to serve as a Lead Plaintiff in the class action, you must petition the Court on or before the Lead Plaintiff Motion deadline.\nKSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation\xe2\x80\x99s premier boutique securities litigation law firms.

Key Points: 
  • b'NEW ORLEANS, May 14, 2021 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (\xe2\x80\x9cKSF\xe2\x80\x9d) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits:\nRomeo Power, Inc. (RMO) f/k/a RMG Acquisition Corp. (RMG)\nIf you purchased shares of the above companies and would like to discuss your legal rights and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner, Lewis Kahn, toll-free at 1-877-515-1850, via email (Lewis.Kahn@KSFcounsel.com), or via the case links above.\nIf you wish to serve as a Lead Plaintiff in the class action, you must petition the Court on or before the Lead Plaintiff Motion deadline.\nKSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation\xe2\x80\x99s premier boutique securities litigation law firms.
  • KSF serves a variety of clients \xe2\x80\x93 including public institutional investors, hedge funds, money managers and retail investors \xe2\x80\x93 in seeking to recover investment losses due to corporate fraud and malfeasance by publicly traded companies.
  • KSF has offices in New York, California and Louisiana.\nTo learn more about KSF, you may visit www.ksfcounsel.com .\n'

SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS CCXI, PCT, PTON INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

Saturday, May 15, 2021 - 3:50am

b'NEW ORLEANS, May 14, 2021 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (\xe2\x80\x9cKSF\xe2\x80\x9d) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits:\nPureCycle Technologies, Inc. (PCT) f/k/a Roth CH Acquisition I Co. (ROCH)\nClass Period: 11/16/2020 - 5/5/2021 and/or were holders of Roth securities entitled to participate in the March 16, 2021 shareholder vote on the merger with PureCycle.\nIf you purchased shares of the above companies and would like to discuss your legal rights and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner, Lewis Kahn, toll-free at 1-877-515-1850, via email (Lewis.Kahn@KSFcounsel.com), or via the case links above.\nIf you wish to serve as a Lead Plaintiff in the class action, you must petition the Court on or before the Lead Plaintiff Motion deadline.\nKSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation\xe2\x80\x99s premier boutique securities litigation law firms.

Key Points: 
  • b'NEW ORLEANS, May 14, 2021 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (\xe2\x80\x9cKSF\xe2\x80\x9d) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits:\nPureCycle Technologies, Inc. (PCT) f/k/a Roth CH Acquisition I Co. (ROCH)\nClass Period: 11/16/2020 - 5/5/2021 and/or were holders of Roth securities entitled to participate in the March 16, 2021 shareholder vote on the merger with PureCycle.\nIf you purchased shares of the above companies and would like to discuss your legal rights and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner, Lewis Kahn, toll-free at 1-877-515-1850, via email (Lewis.Kahn@KSFcounsel.com), or via the case links above.\nIf you wish to serve as a Lead Plaintiff in the class action, you must petition the Court on or before the Lead Plaintiff Motion deadline.\nKSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation\xe2\x80\x99s premier boutique securities litigation law firms.
  • KSF serves a variety of clients \xe2\x80\x93 including public institutional investors, hedge funds, money managers and retail investors \xe2\x80\x93 in seeking to recover investment losses due to corporate fraud and malfeasance by publicly traded companies.
  • KSF has offices in New York, California and Louisiana.\nTo learn more about KSF, you may visit www.ksfcounsel.com .\n'

EXELON INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Exelon Corporation - EXC

Saturday, May 15, 2021 - 3:50am

b'Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (\xe2\x80\x9cKSF\xe2\x80\x9d), announces that KSF has commenced an investigation into Exelon Corporation (NasdaqGS: EXC).\nBetween July and October 2019, the Company disclosed that it and its subsidiary, Commonwealth Edison Company (\xe2\x80\x9cComEd\xe2\x80\x9d), had received two grand jury subpoenas from the U.S. Attorney\xe2\x80\x99s Office for the Northern District of Illinois (\xe2\x80\x9cUSAO\xe2\x80\x9d) and that the SEC was investigating their lobbying activities.

Key Points: 
  • b'Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (\xe2\x80\x9cKSF\xe2\x80\x9d), announces that KSF has commenced an investigation into Exelon Corporation (NasdaqGS: EXC).\nBetween July and October 2019, the Company disclosed that it and its subsidiary, Commonwealth Edison Company (\xe2\x80\x9cComEd\xe2\x80\x9d), had received two grand jury subpoenas from the U.S. Attorney\xe2\x80\x99s Office for the Northern District of Illinois (\xe2\x80\x9cUSAO\xe2\x80\x9d) and that the SEC was investigating their lobbying activities.
  • Recently, the court presiding over that case denied the Company\xe2\x80\x99s motion to dismiss in part, allowing the case to move forward.\nKSF\xe2\x80\x99s investigation is focusing on whether Exelon\xe2\x80\x99s officers and/or directors breached their fiduciary duties to Exelon\xe2\x80\x99s shareholders or otherwise violated state or federal laws.\nIf you have information that would assist KSF in its investigation, or have been a long-term holder of Exelon shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn ( lewis.kahn@ksfcounsel.com ), or visit https://www.ksfcounsel.com/cases/nasdaqgs-exc/ to learn more.\nAbout Kahn Swick & Foti, LLC\nKSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation\xe2\x80\x99s premier boutique securities litigation law firms.
  • KSF serves a variety of clients \xe2\x80\x93 including public institutional investors, hedge funds, money managers and retail investors \xe2\x80\x93 in seeking to recover investment losses due to corporate fraud and malfeasance by publicly traded companies.
  • KSF has offices in New York, California and Louisiana.\nTo learn more about KSF, you may visit www.ksfcounsel.com .\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210514005564/en/\n'

BOSTON SCIENTIFIC INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Boston Scientific Corporation - BSX

Saturday, May 15, 2021 - 3:50am

b'Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (\xe2\x80\x9cKSF\xe2\x80\x9d), announces that KSF has commenced an investigation into Boston Scientific Corporation (NYSE: BSX).\nOn November 17, 2020, the Company announced a global recall of all unused inventory of its LOTUS Edge Aortic Valve System, due to \xe2\x80\x9ccomplexities associated with the product delivery system,\xe2\x80\x9d and that "[g]iven the additional time and investment required to develop and reintroduce an enhanced delivery system, the company has chosen to retire the entire LOTUS product platform immediately.\xe2\x80\x9d\nThereafter, the Company and certain of its executives were sued in a securities class action lawsuit, charging them with failing to disclose material information during the Class Period, violating federal securities laws, which remains ongoing.\nKSF\xe2\x80\x99s investigation is focusing on whether Boston Scientific\xe2\x80\x99s officers and/or directors breached their fiduciary duties to its shareholders or otherwise violated state or federal laws.\nIf you have information that would assist KSF in its investigation, or have been a long-term holder of Boston Scientific shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn ( lewis.kahn@ksfcounsel.com ), or visit https://www.ksfcounsel.com/cases/nyse-bsx/ to learn more.\nAbout Kahn Swick & Foti, LLC\nKSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation\xe2\x80\x99s premier boutique securities litigation law firms.

Key Points: 
  • b'Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (\xe2\x80\x9cKSF\xe2\x80\x9d), announces that KSF has commenced an investigation into Boston Scientific Corporation (NYSE: BSX).\nOn November 17, 2020, the Company announced a global recall of all unused inventory of its LOTUS Edge Aortic Valve System, due to \xe2\x80\x9ccomplexities associated with the product delivery system,\xe2\x80\x9d and that "[g]iven the additional time and investment required to develop and reintroduce an enhanced delivery system, the company has chosen to retire the entire LOTUS product platform immediately.\xe2\x80\x9d\nThereafter, the Company and certain of its executives were sued in a securities class action lawsuit, charging them with failing to disclose material information during the Class Period, violating federal securities laws, which remains ongoing.\nKSF\xe2\x80\x99s investigation is focusing on whether Boston Scientific\xe2\x80\x99s officers and/or directors breached their fiduciary duties to its shareholders or otherwise violated state or federal laws.\nIf you have information that would assist KSF in its investigation, or have been a long-term holder of Boston Scientific shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn ( lewis.kahn@ksfcounsel.com ), or visit https://www.ksfcounsel.com/cases/nyse-bsx/ to learn more.\nAbout Kahn Swick & Foti, LLC\nKSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation\xe2\x80\x99s premier boutique securities litigation law firms.
  • KSF serves a variety of clients \xe2\x80\x93 including public institutional investors, hedge funds, money managers and retail investors \xe2\x80\x93 in seeking to recover investment losses due to corporate fraud and malfeasance by publicly traded companies.
  • KSF has offices in New York, California and Louisiana.\nTo learn more about KSF, you may visit www.ksfcounsel.com .\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210514005560/en/\n'

ROOT 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General And Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against Root, Inc. – ROOT

Friday, May 14, 2021 - 11:08pm

If you wish to serve as a lead plaintiff in the class actions, you must petition the Courts by May 18, 2021.\nRoot and certain of its executives are charged with failing to disclose material information in its IPO Registration Statement and Prospectus and/or during the Class Period, violating federal securities laws.

Key Points: 
  • If you wish to serve as a lead plaintiff in the class actions, you must petition the Courts by May 18, 2021.\nRoot and certain of its executives are charged with failing to disclose material information in its IPO Registration Statement and Prospectus and/or during the Class Period, violating federal securities laws.
  • On this news, shares of Root fell $0.18 per share, or 1.46%, to close at $12.17 per share on March 9, 2021, representing a total decline of 54.93% from the Offering price.\nThe first-filed case is Kolominsky v. Root Inc., et al., 21-cv-01197.\nAbout Kahn Swick & Foti, LLC\nKSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation\xe2\x80\x99s premier boutique securities litigation law firms.
  • KSF serves a variety of clients \xe2\x80\x93 including public institutional investors, hedge funds, money managers and retail investors \xe2\x80\x93 in seeking to recover investment losses due to corporate fraud and malfeasance by publicly traded companies.
  • KSF has offices in New York, California and Louisiana.\nTo learn more about KSF, you may visit www.ksfcounsel.com .\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210514005562/en/\n'

CYTODYN 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against CytoDyn, Inc. - CYDY

Friday, May 14, 2021 - 11:06pm

If you wish to serve as a lead plaintiff in the class actions, you must petition the Courts by May 17, 2021.\nCytoDyn and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.

Key Points: 
  • If you wish to serve as a lead plaintiff in the class actions, you must petition the Courts by May 17, 2021.\nCytoDyn and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
  • 3:21-cv-05190\nAbout Kahn Swick & Foti, LLC\nKSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation\xe2\x80\x99s premier boutique securities litigation law firms.
  • KSF serves a variety of clients \xe2\x80\x93 including public institutional investors, hedge funds, money managers and retail investors \xe2\x80\x93 in seeking to recover investment losses due to corporate fraud and malfeasance by publicly traded companies.
  • KSF has offices in New York, California and Louisiana.\nTo learn more about KSF, you may visit www.ksfcounsel.com .\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210514005561/en/\n'

LORDSTOWN 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Lordstown Motors Corp. - RIDE

Friday, May 14, 2021 - 10:50pm

If you wish to serve as a lead plaintiff in this class action, you must petition the Court by May 17, 2021.\nLordstown and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.

Key Points: 
  • If you wish to serve as a lead plaintiff in this class action, you must petition the Court by May 17, 2021.\nLordstown and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
  • On this news, shares of Lordstown plummeted.\nThe first-filed case is Rico v. Lordstown Motors Corp., et al., 21-cv-00616.\nAbout Kahn Swick & Foti, LLC\nKSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation\xe2\x80\x99s premier boutique securities litigation law firms.
  • KSF serves a variety of clients \xe2\x80\x93 including public institutional investors, hedge funds, money managers and retail investors \xe2\x80\x93 in seeking to recover investment losses due to corporate fraud and malfeasance by publicly traded companies.
  • KSF has offices in New York, California and Louisiana.\nTo learn more about KSF, you may visit www.ksfcounsel.com .\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210514005556/en/\n'

Revolo Biotherapeutics to Present at 3rd Annual Treg Directed Therapies Summit

Friday, May 14, 2021 - 1:00pm

b'NEW ORLEANS and LONDON, May 14, 2021 (GLOBE NEWSWIRE) -- Revolo Biotherapeutics (\xe2\x80\x9cRevolo Bio\xe2\x80\x9d or the \xe2\x80\x9cCompany\xe2\x80\x9d), a company developing therapies that reset the immune system to achieve superior long-term remission for patients with autoimmune and allergic diseases, announced today that Dr. Roly Foulkes, Chief Scientific Officer, will present information relating to the Company\xe2\x80\x99s lead autoimmune and allergic disease drug candidates, \xe2\x80\x991805 and \xe2\x80\x981104, during the 3rd Annual Treg Directed Therapies Summit being held virtually on May 18-20, 2021.\nRevolo Biotherapeutics is developing therapies that reset the immune system to achieve superior long-term remission for patients with autoimmune and allergic disease, without the immune system suppression seen with current therapies.

Key Points: 
  • b'NEW ORLEANS and LONDON, May 14, 2021 (GLOBE NEWSWIRE) -- Revolo Biotherapeutics (\xe2\x80\x9cRevolo Bio\xe2\x80\x9d or the \xe2\x80\x9cCompany\xe2\x80\x9d), a company developing therapies that reset the immune system to achieve superior long-term remission for patients with autoimmune and allergic diseases, announced today that Dr. Roly Foulkes, Chief Scientific Officer, will present information relating to the Company\xe2\x80\x99s lead autoimmune and allergic disease drug candidates, \xe2\x80\x991805 and \xe2\x80\x981104, during the 3rd Annual Treg Directed Therapies Summit being held virtually on May 18-20, 2021.\nRevolo Biotherapeutics is developing therapies that reset the immune system to achieve superior long-term remission for patients with autoimmune and allergic disease, without the immune system suppression seen with current therapies.
  • Its two drug candidates, \xe2\x80\x981805 and \xe2\x80\x981104, a protein and a peptide respectively, reset the immune system to prevent the chronic pro-inflammatory immune response that results in autoimmune or allergic disease.
  • \xe2\x80\x981104 is a peptide derived from a natural immune-regulatory protein and is entering Phase 2 clinical development for patients with eosinophilic esophagitis (EoE) and a Phase 2 clinical trial for allergic disease.
  • The disease-agnostic mechanism of action of Revolo Biotherapeutic\xe2\x80\x99s assets provides a potential platform for the development of treatments for multiple autoimmune and allergic diseases.\n'